CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is highly contagious and presents a significant public health issue. Current therapies used to treat coronavirus disease 2019 (COVID-19) include monoclonal antibody cocktail, convalescent plasma, antivirals, immunomodulators, and anticoagu...
Main Authors: | Minh Tuyet Ma, Saiaditya Badeti, Chih-Hsiung Chen, James Kim, Alok Choudhary, Bill Honnen, Charles Reichman, David Calianese, Abraham Pinter, Qingkui Jiang, Lanbo Shi, Renping Zhou, Huanbin Xu, Qingsheng Li, William Gause, Dongfang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.652223/full |
Similar Items
-
The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
by: Dongfang Liu, et al.
Published: (2020-08-01) -
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
by: Yan Yang, et al.
Published: (2020-09-01) -
Molecular Dynamics Simulation Study of the Interaction between Human Angiotensin Converting Enzyme 2 and Spike Protein Receptor Binding Domain of the SARS-CoV-2 B.1.617 Variant
by: Priya Antony, et al.
Published: (2021-08-01) -
A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil
by: Paola Cristina Resende, et al.
Published: (2021-04-01) -
Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell–cell fusion
by: Xuening Wang, et al.
Published: (2021-06-01)